Aphria Inc  

(Public, CVE:APH)   Watch this stock  
Find more results for APH
1.06
-0.02 (-1.85%)
Feb 11 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 1.04 - 1.10
52 week 0.68 - 1.59
Open 1.09
Vol / Avg. 37,326.00/112,105.00
Mkt cap 68.88M
P/E     -
Div/yield     -
EPS -0.09
Shares 64.98M
Beta     -
Inst. own     -
Apr 22, 2016
Q3 2016 Aphria Inc Earnings Release (Estimated) Add to calendar
Jan 18, 2016
Q2 2016 Aphria Inc Earnings Release
  

Key stats and ratios

Q4 (Nov '15) 2015
Net profit margin -21.27% -1186.63%
Operating margin -23.43% -615.78%
EBITD margin - -727.64%
Return on average assets -11.97% -90.40%
Return on average equity -13.47% -96.94%
CDP Score - -

Address

269 Erie St S, PO Box 20009
LEAMINGTON, ON N8H 3C4
Canada

Website links

Description

Aphria, Inc. is a Canada-based company, which is engaged in greenhouse growing business. The Company is a medical marijuana producer. It provides medical marijuana to help reduce muscle spasms, appetite, or symptoms of anxiety and depression. It provides medical marijuana for end-of-life care or a specific medical condition, including multiple sclerosis, spinal cord injury, spinal cord disease, severe pain, cachexia, anorexia, weight loss, cancer, human immunodeficiency virus (HIV)/ acquired immunodeficiency syndrome (AIDS), arthritis and seizures from epilepsy. In addition, the Company provides medical support services through its wholly owned subsidiary Cannway Pharmaceuticals Inc.